Wist u dat uw browser verouderd is?

Om de best mogelijke gebruikerservaring van onze website te krijgen raden wij u aan om uw browser te upgraden naar een nieuwere versie of een andere browser. Klik op de upgrade button om naar de download pagina te gaan.

Upgrade hier uw browser
Ga verder op eigen risico

News

29 July 2022

Is the market still growing?

The outlook of CDMO for active pharmaceutical ingredients (APIs): Is the market still growing?
Read more
16 May 2022

Ofidit and Rephine: Partners in Business

The mutually-beneficial alliance will see the deeply-experienced global GMP auditors assume responsibility for Ofidit’s third-party audit service and stock its audit reports in its extensive library
Read more
29 September 2021

Feestelijke opening nieuwe R&D faciliteit en QC laboratorium

Read more
20 July 2021

Ofipharma/Ofichem secures the Netherlands with extra Propofol supply

Ofipharma and Ofichem have managed to bring in additional stock of Propofol ampoules to the Netherlands. Propofol is an essential anaesthetic in the ventilation of COVID-19 patients.
Read more
20 July 2021

Building of new R&D pilot plant started

Our colleagues in China recently moved in their new office.
Read more